New anesthesia combo may improve safety during lung procedures
NCT ID NCT07409935
First seen Feb 23, 2026 · Last updated Jun 22, 2026 · Updated 15 times
Summary
This study tested whether adding dexmedetomidine to propofol during rigid bronchoscopy (a procedure to examine the airways) leads to more stable heart rates and fewer complications. Fifty adults were randomly assigned to receive either propofol alone or propofol plus dexmedetomidine. The goal was to see if the combination could improve safety and recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS UNDERGOING RIGID BRONCHOSCOPY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cairo University
Cairo, Cairo Governorate, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
propofol and dexmedetomidine
What this could lead to
If successful, this could lead to a more stable and safer anesthesia method for rigid bronchoscopy procedures.
What could go wrong
This is a small, completed Phase 4 trial with only 50 participants, so results may not apply to all patients. The study focuses on short-term outcomes, not long-term benefits.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.